Implications from 1st Circuit’s decision on health care by NH Business Review for Christopher Walsh
Earlier this year on February 18, 2025, the U.S. Court of Appeals for the 1st Circuit issued a significant decision with implications not only for companies in the health care industry, but for any organization doing business with the federal government. Specifically, in United States v. Regeneron Pharmaceuticals Inc., the…
Continue reading →